the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims. . .
-
.
- .
OFF DEAL
OFF DEAL
181 Used Today
1243 Used Today
80 Used Today
77 Used Today
38 Used Today
273 Used Today
323 Used Today
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims. . .
181 Used Today